Change 5-day change 1-year change 3-year change Capi.($)
-9.09%-9.09% - - 30.31M
-0.82%-3.57%-3.71%+12.92% 48.41B
-1.29%+0.85%+411.90%+546.06% 45.01B
-3.20%-0.76%+38.11%+18.36% 44.07B
-1.89%-2.25%+2.83%+80.93% 40.73B
-1.72%-3.07%+13.76%+43.40% 33.21B
-0.17%+2.68% - - 17.77B
-0.07%-0.52%+21.34%+117.49% 16.5B
-0.56%-1.85%+11.53%+30.40% 14.45B
-2.68%-2.60%+71.21%+37.36% 13.77B
Average -2.15%+0.20%+70.87%+110.87% 30.44B
Weighted average by Cap. -1.54%-0.12%+86.33%+131.34%
Logo Ophthalix Inc
Wize Pharma Inc, formerly Ophthalix, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the treatment of ophthalmic disorders, including dry eye syndrome (DES) and other inflammatory conditions. The Company markets, sells and distributes a formula known as LO2A, which protects ocular surface tissues. LO2A is a drug developed for the treatment of DES and other ophthalmological illnesses, including conjunctivochalasis (CCH) and sjogren's syndrome (sjogren's).
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!